February 2025

Over the past decades, obesity has reached epidemic proportions, now affecting more than 1 billion people worldwide. Childhood obesity, in particular, is rising at an alarming rate. According to the World Obesity Federation, the number of children with obesity is expected to double between 2020 and 2035. Obesity carries serious health consequences, strains national healthcare systems, and reduces overall quality of life.

A study using a new animal model of Alzheimers disease suggests a potential breakthrough in treatment strategies. Current therapies mainly focus on blocking just one of the toxic proteins associated with the disease, but this discovery could pave the way for more comprehensive approaches.

Post Graduate from any one among following branch with NET qualification. Zoology, Pharmacy, Industrial Biotechnology, Biotechnology, Chemistry, any relevant subject of life sciences. Natural Farming vs Conventional farming, Understanding the Translational Dynamics of Microbiome, Drug and Pesticide residues in Animal Products.

Deciphering the molecular processes underlying oxidative stress-induced ovarian reserve decline and identifying potential therapeutic strategies for impeding Premature Ovarian Ageing. A first-class Postgraduate Degree, including integrated postgraduate degrees, in Life Sciences OR a Postgraduate Degree in a professional course such as M.V.Sc., M.Tech, M.Sc., or M.Pharm, with specialization in Biotechnology, Biochemistry, Microbiology, or Immunology, and awarded with first division.

ECHS Cell, Sts HQ Yol invites applications to engage following Medical, Para Medical and Non-Medical Staff on contractual basis In ECHS Polyclinic Yol, Hamirpur, Dehragogpipur, Sarkaghat and Regional Center Yol for a period of one year for ESM and 11 months.

Development of Novel EV-based Therapeutic Strategies for the Treatment of Inherited Krabbe Disease, a Type of Lysosomal Storage Disease. M.Sc Biotechnology, Biochemistry, Microbiology, Molecular Biology, Biomedical Science, Life Science; M.Tech.Biotechnology, Biomedical Engineering; M.Pharm. with first class with 2 years of research experience.

Candidates having Ph.D Degree in Bioinformatics, Biotechnology, Botany, Life Sciences, Plant Molecular Biology or equivalent and fulfilling the guidelines. Candidates with exhaustive work experience in the laboratory with plant molecular biology, biochemistry and, or bioinformatics will be preferred.

Basic knowledge of molecular and immunological techniques and animal handling. BSL-3 handling and experimentation is desirable. Exploration of Immunopathogenesis of extra-intestinal organ involvement in patients with Celiac disease. Masters degree in any branch of Life Sciences from a recognized University.

Supervise and lead the team of analytical development, Analytical method validation, technology transfer, forced degradation study, preformulation study, dissolution studies, Extractable and Leachable and technical query handling. Candidates must have exposure of Pharma regulatory approved organisations USFDA, MHRA, Eu and other Major regulatory bodies

Exposure to OSD Manufacturing operations like Granulation, Compression, Pellet coating, Capsule filling, Primary Packing and Secondary Packing. Expertise in e-BPR and e-log will be added advantage. Experience in analysis of Solid Oral - FP, In-process or Stability samples. Experience of HPLC, UV spectrophotometer and Dissolution Tester operation. Experience of Analytical Method Validation/Transfer Solid Oral. Experience of GC, ICPMS and/or LCMS operation.